Cleared Traditional

K221693 - Elecsys Anti-HCV II (08837031190)

K221693 is an FDA 510(k) clearance for Elecsys Anti-HCV II (08837031190), manufactured by Roche Diagnostics. The device is a Class 2 Microbiology device with product code MZO cleared through the Traditional 510(k) pathway after a 208-day FDA review.

K221693 · Roche Diagnostics · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
208d
Days
Class 2
Risk

K221693 is an FDA 510(k) clearance for the Elecsys Anti-HCV II (08837031190). Classified as Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (product code MZO), Class II - Special Controls.

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on January 4, 2023 after a review of 208 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3169 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostics devices

FDA 510(k) Submission Details - K221693

510(k) Number K221693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 10, 2022
Decision Date January 04, 2023
Days to Decision 208 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
106d slower than avg
Panel avg: 102d · This submission: 208d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MZO Device Classification - Class 2, Special Controls

Product Code MZO Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3169
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.